Aligos Therapeutics, Inc. short interest in 2024
In 2024, Aligos Therapeutics, Inc.'s disclosed short interest ran from 1.12% of shares outstanding on 12 Jan 2024 to 16.65% on 31 Dec 2024, a change of +15.53 percentage points. The year's high was 16.65% on 31 Dec 2024 and its low 0.48% on 15 Mar 2024, averaging 4.43% across 16 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 7.97 days on 14 Jun 2024. Full history: Aligos Therapeutics, Inc..
Cite this page
By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2024 in figures
- Start of year
- 1.12% (12 Jan 2024)
- End of year
- 16.65% (31 Dec 2024)
- Change
- +15.53 pp
- High
- 16.65% (31 Dec 2024)
- Low
- 0.48% (15 Mar 2024)
- Average
- 4.43%
- Highest days to cover
- 7.97 (14 Jun 2024)
- SEC filings marked
- 8
Every report in 2024
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2024 | 1.12% | 4.51 | |
| 31 Jan 2024 | 1.19% | 4.68 | |
| 29 Feb 2024 | 0.49% | 1.00 | |
| 15 Mar 2024 | 0.48% | 1.00 | 10-K filed, results (8-K) |
| 28 Mar 2024 | 1.15% | 2.48 | |
| 15 Apr 2024 | 0.87% | 1.85 | |
| 30 Apr 2024 | 1.11% | 3.71 | |
| 15 May 2024 | 1.41% | 6.48 | 10-Q filed, results (8-K) |
| 31 May 2024 | 2.38% | 6.75 | |
| 14 Jun 2024 | 2.37% | 7.97 | |
| 28 Jun 2024 | 2.76% | 2.93 | |
| 15 Aug 2024 | 10.17% | 1.00 | 10-Q filed, results (8-K) |
| 15 Nov 2024 | 8.12% | 1.00 | 10-Q filed, results (8-K) |
| 29 Nov 2024 | 7.91% | 1.00 | |
| 13 Dec 2024 | 12.74% | 1.10 | |
| 31 Dec 2024 | 16.65% | 1.23 |
See also: Aligos Therapeutics, Inc.'s full history · most shorted US stocks of 2024 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.